Navigation Links
Lung cancer conference to focus on new diagnostic techniques, potential treatments
Date:1/5/2012

SAN DIEGO -- Lung cancer is the most commonly diagnosed cancer in the United States and often the most fatal unless caught early, but scientists are working on ways to improve their understanding of the disease.

Several hundred of scientists will gather in San Diego at the San Diego Marriott Marquis & Marina during Jan. 8-11, 2012, for the AACR-IASLC Joint Conference on Molecular Origins of Lung Cancer: Biology, Therapy and Personalized Medicine.

The conference is jointly sponsored by the American Association for Cancer Research and the International Association for the Study of Lung Cancer.

Media are welcome to attend the conference and can register by contacting Jeremy Moore at Jeremy.Moore@aacr.org.

The conference will host a media briefing, entitled "Lung Cancer Diagnosis: Pitfalls, Challenges and the Path Ahead," on Tuesday, Jan. 10 at 1:00 p.m. PT (4:00 p.m. ET). The briefing will be held in the Atlanta/Chicago room of the San Diego Marriott Marquis & Marina.

The following leaders in lung cancer are scheduled to speak at the press conference:

  • Roy Herbst, M.D., Ph.D., chief of medical oncology and associate director for translational research at the Yale Cancer Center;
  • David P. Carbone, M.D., Ph.D., Harold L. Moses chair in cancer research, director of the Specialized Program of Research Excellence in Lung Cancer and co-leader of the Thoracic/Head and Neck Research Program at the Vanderbilt-Ingram Cancer Center; and
  • Paul A. Bunn, M.D., professor and James Dudley chair in cancer research at the University of Colorado School of Medicine.

Reporters who cannot attend in person can participate using the following information:

U.S./Canada (Toll Free): 888-647-7462

International (Toll): 201-604-0169

Conference leaders have also designated the following research as newsworthy:

  • Estrogen-Targeting Drug Combo May Help Prevent Lung Cancer
  • Researchers Map Potential Genetic Origins, Pathways of Lung Cancer in Never-Smokers
  • Ganetespib Showed Activity in KRAS-Mutant NSCLC as Monotherapy and in Combinations
  • Precancer Markers Identified in Airway Epithelium Cells of Healthy Smokers
  • Sorafenib Effective in Patients With Non-Small Cell Lung Cancer, but Low Survival Rates Reported
  • Sensitive Detection Method Analyzes Circulating Tumor Cells in Patients With Lung Cancer
  • Genetic Composition of Multicentric Lung Tumors Appears to be Similar


'/>"/>
Contact: Jeremy Moore
Jeremy.Moore@aacr.org
215-446-7109
American Association for Cancer Research
Source:Eurekalert

Related biology news :

1. MU researchers photoacoustic device finds cancer cells before they become tumors
2. New stage in fighting pancreatic cancer
3. Gene identified in increasing pancreatic cancer risk
4. Cleveland Clinic researcher discovers genetic cause of thyroid cancer
5. Penn engineers develop more effective MRI contrast agent for cancer detection
6. Drugs used to overcome cancer may also combat antibiotic resistance: McMaster researchers
7. Potential anti-cancer treatment method wins Kaye Award
8. Wayne State study finds soybean compounds enhances effects of cancer radiotherapy
9. Cancer from fetal exposure to carcinogens depends on dose, timing
10. AACR & IASLC to host molecular origins of lung cancer conference
11. London researchers lead innovative new cancer treatment study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/5/2017)... 2017  The Allen Institute for Cell Science today ... one-of-a-kind portal and dynamic digital window into the human ... first application of deep learning to create predictive models ... and a growing suite of powerful tools. The Allen ... future publicly available resources created and shared by the ...
(Date:4/5/2017)... , April 4, 2017 KEY FINDINGS ... anticipated to expand at a CAGR of 25.76% during ... diseases is the primary factor for the growth of ... report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global ... product, technology, application, and geography. The stem cell market ...
(Date:4/3/2017)... 3, 2017  Data captured by IsoCode, ... detected a statistically significant association between the ... treatment and objective response of cancer patients ... predict whether cancer patients will respond to ... well as to improve both pre-infusion potency testing ...
Breaking Biology News(10 mins):
(Date:8/16/2017)... , ... August 16, 2017 , ... ... into a different cell type. Many treatments for specific cancers, such as breast, ... of targeted treatment is androgen deprivation therapy for advanced prostate cancer. , ...
(Date:8/16/2017)... year,s edition of the Inc. 5000 features a now-familiar name: BioPoint ( ... the list for the third year in a row. Now in its ... on a set of quantitative metrics. In addition, BioPoint was also named ... Bay State . ... 5000 ...
(Date:8/15/2017)... San Diego, CA (PRWEB) , ... August 15, ... ... science company pioneering graphene biosensors that accelerate pharmaceutical and biotherapeutics development, announces the ... reduces the number of steps needed to gain kinetic binding data for a ...
(Date:8/15/2017)... (PRWEB) , ... August 15, 2017 , ... The ... time on Immuno-Oncology 360° (IO360°) programming through a series of upcoming panels and events. ... February 7-9, 2018, at The Roosevelt Hotel in New York City. , “With our ...
Breaking Biology Technology: